Quest for a Cure 2019

  • Description
  • FAQ
  • Comments
  • Supporters

The 10th annual Quest for a Cure Walkathon will be held Sunday, September 22, 2019 at VFW Park in Royal Oak, Michigan.

This event is organized by a group of Michigan families on behalf of their children with Rett Syndrome, including the Cardinalis (Gia), the MacDonalds (Annie), the Petersons (Jillian), the Pettys (Hailey), the Rokickis (Olivia), the Scappaticcis (Isabella), and the Weinrauchs (Emily).

While we certainly encourage everyone to attend the walkathon – it's always a great day for the entire family with good food, good fun, and great raffle prizes – we hope even those who can't make it will consider making a donation in support of our event!

For more information on the event and how to participate, click here to visit the website.

What is Rett Syndrome?

Rett Syndrome is serious lifelong neurological disorder that is caused by random mutations in a gene called MECP2. Diagnosed almost exclusively in girls, symptoms typically appear in toddlerhood. Many children with Rett are unable to speak, walk or use their hands. Breathing problems, feeding tubes, seizures, anxiety, gastrointestinal and orthopedic issues are common.

Despite the debilitating nature of the disorder our girls are so much more than a laundry list of symptoms. Their beauty and their strength inspire and motivate us.

Rett Syndrome stands apart from other neurological disorders due to the dramatic reversibility of symptoms in animal models. Our confidence that Rett Syndrome is curable guides our every decision.

Learn more about Rett here.

Who is RSRT?

The Rett Syndrome Research Trust (RSRT) was launched in 2008 with a singular goal: to drive research to a cure for Rett Syndrome and related MECP2 disorders. As one of the few neurological disorders to demonstrate dramatic symptom reversal in the lab, Rett Syndrome has captured the attention of the world's premiere university and pharmaceutical industry scientists. RSRT is operating at the nexus of this activity, leading and advancing the research agenda.

In 2017 RSRT launched a three-year, $33 million strategic plan called Roadmap to a Cure. The plan prioritizes four scientific approaches that attack the disorder at its genetic core and offer the possibility of a profound reversal. Roadmap to a Cure is the only comprehensive plan ever developed by any organization anywhere to advance a cure for Rett Syndrome.

By funding the most Rett research worldwide, $58 million since 2008, we strive to put ourselves out of business as soon as possible.

Learn more about RSRT here.

Supporters (2)

  1. Robert Ficano 
    18 hours ago
  2. Margery Sorbilli 
    3 weeks ago

This is a unique website which will require a more modern browser to work!

Please upgrade today!